North America Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027: COVID-19 Impact - AI in Epidemic Outbreak Prediction and Response - ResearchAndMarkets.com

The "North America Artificial Intelligence in Healthcare Diagnosis Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Diagnostic Tool; Application; End User; Service; and Country" report has been added to ResearchAndMarkets.com's offering.

The North America artificial intelligence in healthcare diagnosis market is projected to reach from US$ 1,716.42 million in 2019 to US$ 32,009.61 million by 2027. This represents a CAGR of 44.3% from 2020 to 2027.

The growth of the North America artificial intelligence in healthcare diagnosis market is primarily attributed to rising adoption of Artificial Intelligence (AI) in disease identification and diagnosis, increasing investment in AI healthcare start-ups.

The healthcare industry has always been a leader in innovation. The constant mutating of diseases and viruses makes it difficult to stay ahead of the curve. However, with the help of artificial intelligence and machine learning algorithms, it continues to advance, creating new treatments and helping people live longer and healthier. A study published by The Lancet Digital Health compared the performance of deep learning a form of artificial intelligence (AI) in detecting diseases from medical imaging versus that of healthcare professionals, using a sample of studies carried out between 2012 and 2019.

The study found that, in the past few years, AI has become more precise in identifying disease diagnosis in these images and has become a more feasible source of diagnostic information. With advancements in AI, deep learning may become even more efficient in identifying diagnosis in the coming years. Moreover, it can help doctors with diagnoses and notify when patients are weakening so that the medical intervention can occur sooner before the patient needs hospitalization. It can save costs for both the hospitals and patients. Additionally, the precision of machine learning can detect diseases such as cancer quickly, thus saving lives.

In 2019, the medical imaging tool segment accounted for a larger share of the North America artificial intelligence in healthcare diagnosis market. Its growth is attributed to an increasing adoption of AI technology for diagnosis of chronic conditions is likely to drive the growth of diagnostic tool segment in the North America artificial intelligence in healthcare diagnosis.

In 2019, the radiology segment held a considerable share of the for North America artificial intelligence in healthcare diagnosis market, by the application. This segment is also predicted to dominate the market by2027 owing to rising demand for AI based application for radiology.

A few major primary and secondary sources for the artificial intelligence in healthcare diagnosis market included US Food and Drug Administration, and World Health Organization.

Key Topics Covered:

1. Introduction

2. Artificial Intelligence in Healthcare Diagnosis Market Key Takeaways

3. Research Methodology

4. Artificial Intelligence in Healthcare Diagnosis Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Artificial Intelligence in Healthcare Diagnosis Market Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Adoption of Artificial Intelligence (AI) in Disease Identification and Diagnosis

5.1.2 Increasing Investment in AI Healthcare Start ups

5.2 Market Restraints

5.2.1 Lack of skilled AI Workforce and Ambiguous Regulatory Guidelines for Medical Software

5.3 Market Opportunities

5.3.1 Increasing Potential in AI Technology in Healthcare

5.4 Future Trends

5.4.1 AI in Epidemic Outbreak Prediction and Response

5.5 Impact analysis

6. Artificial Intelligence in Healthcare Diagnosis Market By Diagnostic Tool

6.1 Overview

6.2 Artificial Intelligence in Healthcare Diagnosis Market Revenue Share, by Diagnostic Tool (2019 and 2027)

6.3 Medical Imaging Tool

6.4 Automated Detection System

6.5 Others

7. Artificial Intelligence in Healthcare Diagnosis Market Analysis, by Application

7.1 Overview

7.2 Artificial Intelligence in Healthcare Diagnosis Market Revenue Share, by Application (2019 and 2027)

7.3 Eye Care

7.4 Oncology

7.5 Radiology

7.6 Cardiovascular

7.7 Others

8. Artificial Intelligence in Healthcare Diagnosis Market By End-User

8.1 Overview

8.2 Artificial Intelligence in Healthcare Diagnosis Market, by End-User, 2019 and 2027 (%)

8.3 Hospital and Clinic

8.4 Diagnostic Laboratory

8.5 Home Care

8.5.3 Doctors

8.5.4 Patients

9. Artificial Intelligence in Healthcare Diagnosis Market By Service

9.1 Overview

9.2 Artificial Intelligence in Healthcare Diagnosis Market, by Service, 2019 and 2027 (%)

9.3 Tele-Consultation

9.4 Tele-Monitoring

9.5 Others

10. Artificial Intelligence in Healthcare Diagnosis Market Country Analysis

11. Impact Of COVID-19 Pandemic on North America Artificial Intelligence in Healthcare Diagnosis Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Company Profiles

12.1 Key Facts

12.2 Business Description

12.3 Products and Services

12.4 Financial Overview

12.5 SWOT Analysis

12.6 Key Developments

• General Electric Company
• Koninklijke Philips N.V.
• Aidoc, Arterys Inc.
• Icometrix, IDx Technologies Inc.
• MaxQ AI Ltd.
• Caption Health, Inc.
• Zebra Medical Vision, Inc.
• Siemens Healthcare Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/j01mrq

View source version on businesswire.com: https://www.businesswire.com/news/home/20201022005630/en/